Thomas Poiret

Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial

Aliaksandr Skrahin, Raija Ahmed, Giovanni Ferrara et al. · The Lancet Respiratory Medicine · 2014 · 136 citations

Translational Medicine, Pulmonary Tuberculosis, Tuberculosis Prevention +8

Mesothelin-Specific CAR T Cells Target Ovarian Cancer

Esther Schoutrop, Ibrahim El‐Serafi, Thomas Poiret et al. · Cancer Research · 2021 · 110 citations · Full text

Tumor-infiltrating lymphocytes (TILs) from patients with glioma

Zhenjiang Liu, Qingda Meng, Jiří Bártek et al. · OncoImmunology · 2016 · 85 citations · Full text

Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer

Qingda Meng, Zhenjiang Liu, Elena Rangelova et al. · Journal of Immunotherapy · 2016 · 81 citations

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models

Esther Schoutrop, Thomas Poiret, Ibrahim El‐Serafi et al. · Journal for ImmunoTherapy of Cancer · 2023 · 51 citations · Full text